Winter Innovations, Inc. — SEC Form D Filing

Winter Innovations, Inc. filed an SEC Form D on September 1, 2026, reporting $1.26M raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
September 1, 2026
Amount reported
$1.26M
Round stage
Seed
Industry
Medical Devices
Website
https://www.winter-innovations.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Current orthopedic surgical stitching methods can be inefficient, cause more needle holes, lead to tissue shredding, and require more suture material, impacting reliability for surgeons and patients.

Solution

Winter Innovations develops medical devices, including a patented two-part needle technology (EasyWhip®) and advanced stitching solutions (WhipLock™), designed to make orthopedic surgical stitching more efficient, reliable, and to minimize tissue damage during procedures like tendon and ligament repair.

Why now

Advances in medical technology and a demand for improved surgical outcomes and efficiency in orthopedic procedures drive the need for innovative suturing and graft preparation tools.

Verdict

This cleared because investors saw a patented, incremental efficiency gain in a high-stakes, well-funded medical procedure, not because the company was disrupting an entire market. They were implicitly betting on the clinical efficacy proving out for orthopedic surgeons and the sales team's ability to navigate established hospital procurement channels. Upside was limited by the specialized nature of the surgical niche and the long sales cycles inherent in medical device adoption, which often slows revenue acceleration.

Source: SEC EDGAR Form D filing